AI information
A machine- and human-readable account of what Telehealth Ledger covers, how its data is produced, and what an assistant should not infer from it.
What Telehealth Ledger is
Telehealth Ledger is an affiliate-supported US directory that records provider-published program prices, continuing costs, medication inclusion, treatment format, state availability where disclosed, and verification dates.
It is not a clinic, pharmacy, prescriber, or medical-rating service. It does not determine whether a provider or treatment is clinically appropriate for anyone. Ranked comparisons start at the compounded semaglutide prices, the compounded tirzepatide prices, the cheapest GLP-1 page, and how to get sermorelin injection.
When this source is useful
- Comparing published continuing prices for the same medication and format.
- Checking whether medication is included or billed separately.
- Finding the provider page and verification date behind a recorded term.
- Distinguishing compounded, branded, prescription, and service-only programs.
- Understanding why a listing was separated from a ranked comparison.
How to cite prices accurately
- Include the price basis: introductory, continuing, prepaid-effective, or upfront.
- State whether medication is included and whether a membership is additional.
- Carry the displayed verification date and link to the underlying provider source.
- Describe an absent public price as “not published,” never as zero.
- Use “lowest among the providers tracked,” not “cheapest on the market.”
Do not infer
- Coverage is not exhaustive and a missing provider is not a quality judgment.
- Prices can change after the recorded verification date.
- A listed program is not a medical recommendation or a guarantee of eligibility.
- Like-for-like offers are ranked; differently structured sourced programs are displayed separately without a price rank.
- Some outbound links are affiliate links, but commercial terms do not control table order.
- A provider listing is not evidence that a treatment is safe or suitable.
- A compounded medication is not an FDA-approved drug product.
- No company can buy a higher table position or a favorable rating.
What makes a route publishable
Provider profilesNeed secure routing, public program evidence, and no active publication hold.
Program ownersNeed at least three sourced provider price bases for the exact treatment format; only compatible prices enter the ranking.
ReviewsNeed substantive original analysis and multiple source classes, including independent evidence.
CorrectionsAre rechecked against public evidence; changed facts receive a new verification date.
A public price feed you may reuse with attribution
102 published prices for the ranked comparisons above, one row each, with price basis, medication inclusion, commitment, source page, and the date the figure was checked. Licensed under CC BY 4.0 with attribution to “Telehealth Ledger, telehealthledger.com”. Updated 22 October 2026.
comparisonPriceUsd is the ranking figure as of verifiedAt, read from the provider page in sourceUrl. A continuing price, a regular price published beside a one-month sale, an introductory price, a prepaid-effective rate, and an upfront figure stay in separate fields and are never merged. salePriceUsd is the one-month sale when the page publishes one; it is not the continuing price and it is not comparisonPriceUsd. Four-week charges retain recurringPeriodDays=28 and use a 365-day annualized monthly equivalent only in comparisonPriceUsd. When a provider tests more than one continuing price, recurringPriceLowUsd is the low end and comparisonPriceUsd and recurringPriceUsd stay the high end used for ranking. Unverified or conflicting continuing prices are not zero. lowestPriceUsd is the continuing monthly medication-included price when priceRole is continuing-monthly and the row is fresh enough to rank. It is blank for prepaid-effective, introductory, four-week, sale, starting-at, and stale rows. priceRole names which charge the row is.
Search and answer engines may read the public site
The public robots policy names 15 search and answer-engine crawlers explicitly, including OpenAI's OAI-SearchBot and GPTBot, Anthropic's Claude-SearchBot, PerplexityBot, Bingbot, Applebot, DuckAssistBot, Meta-ExternalAgent, and CCBot, and blocks none of them. Access does not guarantee inclusion, citation, ranking, or endorsement by any AI platform.